STOCK TITAN

Butterfly Network (BFLY) Stock News, Jan-Apr 2022

BFLY NYSE

Butterfly Network, Inc. develops semiconductor-based ultrasound devices, programmable cloud software and AI for medical imaging and sensing. Its Ultrasound-on-Chip technology underpins handheld whole-body ultrasound systems such as Butterfly iQ, iQ+ and iQ3, along with enterprise workflow software including Compass AI and developer tools such as Butterfly Garden.

Company news commonly covers financial results, point-of-care ultrasound adoption, FDA-cleared AI tools such as its Gestational Age Tool, U.S. and international sales channels, and platform initiatives. Updates also address Butterfly Embedded, the company’s licensing and co-development effort for applying its ultrasound chip and software platform in partner-built products, as well as board and leadership changes tied to medtech, clinical strategy and commercialization.

Rhea-AI Summary

Butterfly Network, Inc. (NYSE: BFLY) announced its significant findings from a study published in NEJM Evidence, demonstrating the potential of its handheld ultrasound technology to democratize obstetric care. The study, conducted from September 2018 to June 2021, involved 4,695 pregnant participants in North Carolina and Zambia. Results showed that untrained midwives could accurately assess gestational age using the Butterfly iQ probe, equating their performance to certified sonographers. Backed by the Bill and Melinda Gates Foundation, this initiative aims to enhance ultrasound access in low-resource settings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.09%
Tags
none
-
Rhea-AI Summary

Butterfly Network, Inc. (NYSE: BFLY) will announce its first quarter 2022 financial results on May 5, 2022, before market opening. Dr. Todd Fruchterman, the CEO, will lead a conference call and webcast at 8:30 AM ET on the same day to discuss financial performance and operational updates. The event will be accessible via the company's website. Butterfly is known for its innovative handheld ultrasound technology aimed at improving global health access, leveraging its Ultrasound-on-Chip™ technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.09%
Tags
conferences earnings
-
Rhea-AI Summary

FUJIFILM Sonosite has filed a patent infringement lawsuit against Butterfly Network (BFLY) in Delaware, claiming infringement of seven patents related to point-of-care ultrasound technology. The patents cover critical aspects of ultrasound imaging, including the use of mobile devices and graphical interface elements. FUJIFILM Sonosite seeks damages for Butterfly's alleged unauthorized use and sale of its IQ/IQ+ products. Rich Fabian, COO, emphasized the company's commitment to protecting its significant R&D investments and intellectual property rights in the U.S. and worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.05%
Tags
none
Rhea-AI Summary

Butterfly Network (NYSE: BFLY) received a $5 million grant from the Bill & Melinda Gates Foundation to enhance maternal and fetal health in Sub-Saharan Africa. The funding aims to provide 1,000 healthcare workers with Butterfly iQ+ ultrasound probes, distributing 500 each in Kenya and South Africa. This initiative targets improving access to medical imaging in resource-limited settings, addressing high pregnancy-related morbidity and mortality. The company plans to document best practices for ultrasound use and develop new health capabilities in its mobile application.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.05%
Tags
none
-
Rhea-AI Summary

Butterfly Network reported significant financial growth with 2021 revenue reaching $62.6 million, marking a 35.3% increase over 2020.

Fourth-quarter revenue rose 21.3% to $19.0 million, driven by a 15.1% increase in product revenue. However, operating expenses surged 71.0% to $52.8 million, leading to a net loss of $15.2 million for Q4.

For 2022, the company projects revenue growth of 33% to 41%, expecting a net loss between $225 million and $245 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.81%
Tags
-
Rhea-AI Summary

Butterfly Network has launched Butterfly Blueprint, a system-wide platform that enhances ultrasound deployment in hospitals. This integrated solution, which utilizes Caption Health's AI-guided software, aims to improve clinical decision-making by providing efficient access to diagnostic imaging. The platform will facilitate better patient care through faster access to ultrasound insights across various healthcare settings, aligning with the company's mission to enhance global health equity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.81%
Tags
Rhea-AI Summary

Butterfly Network, Inc. (NYSE: BFLY) will participate in Cowen's 42nd Annual Health Care Conference from March 7-9, 2022. CEO Dr. Todd Fruchterman is scheduled for a virtual fireside chat on March 9 at 10:30 AM ET. A live webcast and archived recording will be accessible via the Butterfly Network investor website. Founded in 2011, Butterfly Network revolutionizes medical imaging with its handheld ultrasound technology, aiming for health equity worldwide. Its products, Butterfly iQ+ and Butterfly iQ+ Vet, are available for purchase across multiple countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
conferences
-
Rhea-AI Summary

Butterfly Network (NYSE: BFLY) announced it will release its fourth quarter and full year 2021 financial results on February 28, 2022. The report will be followed by a conference call at 8:30 am ET, where executives will discuss the results and operational updates. The call will be available via webcast on Butterfly's Investor Relations website. Founded in 2011, Butterfly is known for its innovative handheld ultrasound technology, the iQ+, aimed at improving medical imaging accessibility worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
conferences earnings
-
Rhea-AI Summary

Butterfly Network has partnered with Ambra Health to enhance interoperability for bedside imaging data, crucial for improving clinical decision-making in healthcare systems. This collaboration aims to integrate Butterfly's Blueprint platform with Ambra's imaging management solutions, allowing for rapid access to ultrasound information across hospitals. Notably, research indicates that point-of-care ultrasonography can significantly improve diagnostic accuracy and reduce costs. The integrated solution is set for commercial launch in Q1 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.48%
Tags
partnership
Rhea-AI Summary

Butterfly Network, Inc. (NYSE: BFLY) announced preliminary, unaudited revenue results for Q4 and full year 2021. Q4 revenue is expected to be between $17.9 million and $18.9 million, marking a 14% to 21% increase year-over-year. For the entire year, revenue is projected at $61.5 million to $62.5 million, up 33% to 35% compared to 2020. The company highlighted a significant deployment collaboration with the University of Rochester Medical Center. These preliminary figures are subject to revisions pending full financial review.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.46%
Tags
none

FAQ

What is the current stock price of Butterfly Network (BFLY)?

Butterfly Network (BFLY) last closed at $5.40.

What is the market cap of Butterfly Network (BFLY)?

The market cap of Butterfly Network (BFLY) is approximately $1.4B.